Accuray Inc
NASDAQ:ARAY

Watchlist Manager
Accuray Inc Logo
Accuray Inc
NASDAQ:ARAY
Watchlist
Price: 0.3704 USD -11.79% Market Closed
Market Cap: $42m

Accuray Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Accuray Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Accuray Inc
NASDAQ:ARAY
Other Items
-$8m
CAGR 3-Years
N/A
CAGR 5-Years
-151%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
Other Items
-$1.8B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Edwards Lifesciences Corp
NYSE:EW
Other Items
-$452.7m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Other Items
-$4.1B
CAGR 3-Years
-21%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Other Items
-$251m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Other Items
$1.2B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Accuray Inc
Glance View

Market Cap
42m USD
Industry
Health Care

Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

ARAY Intrinsic Value
4.3701 USD
Undervaluation 92%
Intrinsic Value
Price

See Also

What is Accuray Inc's Other Items?
Other Items
-8m USD

Based on the financial report for Dec 31, 2025, Accuray Inc's Other Items amounts to -8m USD.

What is Accuray Inc's Other Items growth rate?
Other Items CAGR 10Y
6%

Over the last year, the Other Items growth was -1 056%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett